Student Name
Capella University
NHS-FPX 6004 Health Care Law and Policy
Prof. Name
Date
Dashboard Metrics Evaluation
Introduction to Dashboard Metrics Evaluation
Healthcare organizations commonly utilize performance dashboards to track clinical outcomes and operational performance. These dashboards transform raw data into visual metrics that allow organizations to compare their performance against benchmarks established by national or regional healthcare authorities. According to Helminski et al. (2022), dashboard analytics enable healthcare teams to quickly identify performance trends and areas that require improvement.
The present dashboard evaluation focuses on diabetes management indicators at Mercy Medical Center (MMC). Specifically, it examines three critical clinical metrics used to monitor diabetes care: Hemoglobin A1c (HgbA1c) testing, annual eye examinations, and foot examinations. These indicators are widely recognized as essential measures for preventing complications associated with diabetes. By analyzing these dashboard metrics, healthcare leaders can detect performance gaps and implement targeted strategies to strengthen diabetes management practices within the organization.
Evaluation of Dashboard Metrics
Healthcare agencies have established evidence-based benchmarks to guide effective diabetes monitoring and management. The American Diabetes Association (ADA) recommends that individuals with diabetes receive routine HgbA1c testing as well as annual eye and foot examinations to detect complications at an early stage (Cooksey, 2020). Similarly, the National Healthcare Quality and Disparities Report (NHQDR) recommends that patients undergo at least two HgbA1c tests annually, with a performance benchmark of approximately 79.5% compliance (ADA, 2019).
The Vila Health Dashboard provides performance data for the years 2019 and 2020, organized by four quarterly reporting periods. A detailed review of the data indicates that MMC is experiencing declining performance in certain metrics, particularly HgbA1c testing and foot examination rates. For example, in the third quarter (Q3) of 2020, 78 patients completed HgbA1c testing; however, this number declined to 64 patients in the fourth quarter (Q4). Such a downward trend suggests reduced screening compliance compared with recommended benchmarks.
Foot examination data reveal even greater inconsistencies across the reporting periods. The recorded values for 2020 were 75 patients in Q1, 50 patients in Q2, 48 patients in Q3, and 62 patients in Q4. Although the fourth quarter shows a slight improvement, the overall numbers remain significantly below optimal screening levels.
The importance of routine foot examinations cannot be overstated. Annual foot assessments allow clinicians to detect early signs of neuropathy, infection, or vascular complications. When these examinations are delayed or omitted, patients with diabetes may experience reduced sensation, increased susceptibility to wounds, delayed wound healing, and in severe cases, lower limb amputation (Song & Chambers, 2021). These complications not only reduce patients’ quality of life but also increase healthcare costs due to hospitalization and long-term care.
Similarly, HgbA1c testing is a critical clinical measure that evaluates long-term blood glucose control. It provides an overview of average glucose levels over the previous two to three months and helps clinicians determine whether diabetes is being effectively managed. Several healthcare policies, including those issued by the Centers for Medicare and Medicaid Services (CMS), emphasize preventive screening and routine monitoring of HgbA1c levels as essential components of diabetes care (CMS, 2023). Consequently, MMC must improve both its HgbA1c testing rates and foot examination compliance in order to align with established healthcare standards.
Summary of Key Dashboard Metrics
| Metric | Benchmark Recommendation | MMC Observed Trend | Key Concern |
|---|---|---|---|
| HgbA1c Testing | At least 2 tests per year; benchmark ≈ 79.5% | Decline from 78 (Q3 2020) to 64 (Q4 2020) | Below national benchmark |
| Eye Examination | At least once per year | Data available but not emphasized in dashboard analysis | Requires continued monitoring |
| Foot Examination | Annual examination recommended | Fluctuations: 75 → 50 → 48 → 62 (2020) | Inconsistent screening rates |
Organizational Performance Shortfalls and Informational Gaps
The dashboard provides demographic information for newly registered patients, including race, gender, and age distribution. However, it does not include data on returning patients or individuals who were evaluated in earlier quarters. This absence of longitudinal data limits the ability to identify patterns in patient outcomes or to measure continuity of care.
Available demographic information indicates that White patients represent the largest group receiving services (63%). Additionally, female patients account for approximately 62% of the population served, while male patients represent 38%. Regarding age distribution, individuals between 40 and 64 years constitute the largest proportion (38%) undergoing diabetes-related tests.
Although these statistics provide a general demographic overview, the dashboard lacks sufficient detail to fully evaluate disparities in healthcare delivery. For example, it does not indicate whether certain racial or socioeconomic groups experience lower screening rates or poorer health outcomes. Moreover, the data do not explain the underlying causes behind reduced HgbA1c testing and foot examination rates.
Another significant observation involves the organization’s performance gap in meeting benchmark targets. The data show that HgbA1c compliance improved slightly from 37% in 2019 to 48% in 2020. While this increase represents progress, it remains far below the benchmark recommended by national quality organizations (ADA, 2019). To close this gap, MMC must significantly increase its screening rates and improve care coordination.
Consequences of Not Meeting Prescribed Benchmarks
Failure to meet established diabetes management benchmarks can have significant consequences for patients, healthcare professionals, and the healthcare organization. One major impact is the deterioration in the quality of patient care. When essential screenings such as foot, eye, or HgbA1c tests are delayed or omitted, early detection of complications becomes unlikely. As a result, patients may experience irreversible damage to organs such as the eyes or lower limbs, leading to long-term disability or chronic disease progression (Lv et al., 2023).
Patient satisfaction may also decline when recommended screenings are not consistently performed. Patients often expect healthcare providers to deliver preventive care and timely monitoring. When healthcare systems fail to meet these expectations, trust in the organization may diminish.
From an organizational perspective, failing to meet national quality benchmarks can also result in financial and legal consequences. Healthcare organizations operating under value-based reimbursement models may face reduced reimbursement rates or financial penalties when quality indicators are not met (Jing et al., 2023). Additionally, public reporting of healthcare quality metrics can affect an organization’s reputation, potentially leading to negative publicity and lower patient enrollment.
Operational challenges may also arise. For example, inadequate screening rates could indicate resource constraints, limited physical space, or staffing shortages. If patient volumes increase without adequate clinical infrastructure, healthcare teams may struggle to maintain recommended screening practices. Poor performance in quality metrics can also lead to staff dissatisfaction and higher turnover rates, especially if employees feel unsupported or overwhelmed (Alsadaan et al., 2023).
Support services across the organization may also be affected. Departments such as pharmacy, nutrition, and patient education rely on coordinated care processes. When preventive screening is ineffective, these departments may struggle to manage increasing complications associated with poorly controlled diabetes.
Potential Organizational Consequences
| Area of Impact | Potential Outcome |
|---|---|
| Patient Health | Increased complications, disability, and reduced quality of life |
| Financial Performance | Lower reimbursement and potential regulatory penalties |
| Organizational Reputation | Poor quality ratings and negative public perception |
| Workforce Stability | Increased staff stress and turnover |
| Resource Utilization | Higher costs due to hospitalizations and emergency care |
Assumptions Underlying the Analysis
Several assumptions guide the evaluation of MMC’s dashboard data. First, it is assumed that the organization is committed to delivering high-quality diabetes care and improving patient outcomes. Second, the analysis assumes that the benchmarks established by national healthcare agencies are appropriate performance indicators for diabetes management.
Another assumption is that failure to meet these benchmarks has measurable consequences for both patient outcomes and organizational performance. Research suggests that inadequate diabetes monitoring is associated with increased complication rates and reduced care quality (Song & Chambers, 2021). Therefore, improving screening compliance should directly enhance patient health outcomes.
A Benchmark Underperformance in a Healthcare Organization
Among the three evaluated metrics, HgbA1c testing represents a key area where improvements can significantly enhance diabetes management. The American Diabetes Association recommends routine monitoring of blood glucose levels through HgbA1c testing, typically at least twice per year for patients with stable diabetes and more frequently for individuals with uncontrolled glucose levels.
Frequent monitoring enables healthcare providers to detect complications early and adjust treatment strategies accordingly. If glucose levels remain uncontrolled, patients may develop serious complications such as cardiovascular disease, diabetic retinopathy, neuropathy, and kidney disease (Eyth & Naik, 2023).
Regular HgbA1c monitoring also supports effective disease prevention strategies. When clinicians track glucose trends consistently, they can identify patterns that indicate deteriorating metabolic control. Early intervention can then prevent severe conditions such as hypoglycemia, hyperglycemia, and diabetic nephropathy (Cosic et al., 2023).
Furthermore, routine monitoring encourages patient engagement in diabetes self-management. When patients receive feedback regarding their blood glucose levels, they are more likely to adopt healthier behaviors, including medication adherence, dietary adjustments, and increased physical activity (Lin et al., 2022).
From an organizational perspective, improved screening rates can also optimize resource utilization. Preventive care strategies reduce the need for costly medical interventions, hospitalizations, and emergency services. Consequently, proactive HgbA1c monitoring can improve patient outcomes while simultaneously lowering long-term healthcare expenditures.
Ethical and Sustainable Actions
Addressing the underperformance in HgbA1c testing requires collaborative involvement from multiple stakeholders, including healthcare providers, administrators, and policymakers. Each stakeholder group plays a distinct role in promoting ethical and sustainable healthcare practices.
Healthcare providers, particularly physicians and nurses, are responsible for delivering direct patient care and ensuring that diabetes screening guidelines are followed. Their clinical decisions should align with ethical principles such as autonomy, beneficence, nonmaleficence, and justice (Asadi et al., 2023). For example, educating patients about diabetes management and the importance of regular HgbA1c testing empowers them to make informed decisions about their health (Ernawati et al., 2021).
Healthcare administrators are responsible for overseeing organizational operations and ensuring that adequate resources are available for diabetes screening programs. This includes allocating funding for staff training, implementing quality improvement initiatives, and ensuring transparency in performance monitoring (Bhati et al., 2023).
Policymakers also play a critical role by establishing regulations that encourage preventive healthcare practices. Policies that promote value-based care models and equitable healthcare access can help ensure that all patient populations receive consistent diabetes monitoring and treatment. Additionally, policymakers can support programs that address social determinants of health, thereby reducing disparities in diabetes care (Mogueo et al., 2022).
Through collaborative efforts and ethical decision-making, these stakeholders can implement sustainable strategies that improve diabetes management outcomes at MMC.
Conclusion
The evaluation of dashboard metrics at Mercy Medical Center highlights several performance gaps in diabetes management, particularly in HgbA1c testing and foot examination rates. Although the organization has made some progress, current screening levels remain below national benchmarks. Failure to meet these standards can negatively affect patient outcomes, financial performance, and organizational reputation.
Improving HgbA1c screening practices offers a promising strategy for strengthening diabetes care. By promoting preventive monitoring, patient education, and collaborative stakeholder engagement, MMC can enhance healthcare quality and ensure more effective diabetes management. Ethical leadership and sustainable policy implementation will be essential for achieving these improvements and maintaining long-term organizational success.
References
ADA. (2019). Standards of medical care in diabetes—2019 abridged for primary care providers. Clinical Diabetes, 37(1), 11–34. https://doi.org/10.2337/cd18-0105
Alsadaan, N., Salameh, B., Reshia, F. A. A. E., Alruwaili, R. F., Alruwaili, M., Awad Ali, S. A., Alruwaili, A. N., Hefnawy, G. R., Alshammari, M. S. S., Alrumayh, A. G. R., Alruwaili, A. O., & Jones, L. K. (2023). Impact of nurse leaders behaviors on nursing staff performance: A systematic review of literature. Inquiry: A Journal of Medical Care Organization, Provision and Financing, 60(60), 469580231178528. https://doi.org/10.1177/00469580231178528
Asadi, M., Zahedi, F., Ebrahimpur, M., & Larijani, B. (2023). Ethical challenges in gestational diabetes. Journal of Medical Ethics and History of Medicine. https://doi.org/10.18502/jmehm.v16i6.13470
Bhati, D., Deogade, M. S., & Kanyal, D. (2023). Improving patient outcomes through effective hospital administration: A comprehensive review. Cureus, 15(10). https://doi.org/10.7759/cureus.47731
CMS. (2023). Medicare Diabetes Prevention Program (MDPP) expanded model | CMS. https://www.cms.gov/priorities/innovation/innovation-models/Medicare-diabetes-prevention-program
NHS FPX 6004 Assessment 1 Dashboard Metrics Evaluation
Cooksey, C. (2020). Strategies to improve annual diabetic foot screening compliance at a family clinic. Clinical Diabetes, 38(4), 386–389. https://doi.org/10.2337/cd20-0030
Cosic, V., Jakab, J., Pravecek, M. K., & Miskic, B. (2023). The importance of prediabetes screening in the prevention of cardiovascular disease. Medical Archives, 77(2), 97–104. https://doi.org/10.5455/medarh.2023.77.97-104
Ernawati, U., Wihastuti, T. A., & Utami, Y. W. (2021). Effectiveness of Diabetes Self-Management Education (DSME) in Type 2 Diabetes Mellitus patients: Systematic literature review. Journal of Public Health Research, 10(2), 198–202. https://doi.org/10.4081/jphr.2021.2240
Eyth, E., & Naik, R. (2023). Hemoglobin A1C. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549816/
Helminski, D., Kurlander, J. E., Renji, A. D., Sussman, J. B., Pfeiffer, P. N., Conte, M. L., Gadabu, O. J., Kokaly, A. N., Goldberg, R., Ranusch, A., Damschroder, L. J., & Landis-Lewis, Z. (2022). Dashboards in health care settings: Protocol for a scoping review. JMIR Research Protocols, 11(3), e34894. https://doi.org/10.2196/34894
Jing, S., Yu, Y., & Yuan, B. (2023). Study on the determinants of health professionals’ performance on diabetes management care in China. BMC Primary Care, 24(1). https://doi.org/10.1186/s12875-023-02136-z
Lin, H.-C., Tseng, C.-W., Hsieh, P.-J., Liang, H.-L., Sue, S.-P., Huang, C.-Y., & Lee, M.-Y. (2022). Efficacy of self-management on glucose control in type 2 diabetes mellitus patients treated with insulin. Healthcare, 10(10), 2080. https://doi.org/10.3390/healthcare10102080
Lv, K., Cui, C., Fan, R., Zha, X., Wang, P., Zhang, J., Zhang, L., Ke, J., Zhao, D., Cui, Q., & Yang, L. (2023). Detection of diabetic patients in people with normal fasting glucose using machine learning. BMC Medicine, 21(1). https://doi.org/10.1186/s12916-023-03045-9
Mogueo, A., Defo, B. K., & Mbanya, J. C. (2022). Healthcare providers’ and policymakers’ experiences and perspectives on barriers and facilitators to chronic disease self-management for people living with hypertension and diabetes in Cameroon. BMC Primary Care, 23(1). https://doi.org/10.1186/s12875-022-01892-8
NHS FPX 6004 Assessment 1 Dashboard Metrics Evaluation
Song, K., & Chambers, A. R. (2021). Diabetic foot care. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK553110/
Sørensen, M., Groven, K. S., Gjelsvik, B., Almendingen, K., & Holme, L. G. (2020). The roles of healthcare professionals in diabetes care: A qualitative study in Norwegian general practice. Scandinavian Journal of Primary Health Care, 38(1), 12–23. https://doi.org/10.1080/02813432.2020.1714145